Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy.
Marcus Maximilian MückeBenjamin MaasoumyJulia DietzVictoria T MückeChristian O SimonJesse A CancholaMarcus CornbergEd G MarinsMichael P MannsStefan ZeuzemHeiner WedemeyerChristoph SarrazinJohannes VermehrenPublished in: PloS one (2019)
The performance of the new cobas HCV test was comparable to CAP/CTM in a clinical setting representing a large patient population with HCV GT 1 and 3 treated with DAAs.